AI
| Followers | 690 |
| Posts | 144032 |
| Boards Moderated | 35 |
| Alias Born | 03/10/2004 |
Wednesday, January 24, 2024 4:40:37 PM
By: Investing | January 24, 2024
Crown Castle (NYSE: CCI) reported fourth quarter EPS of $0.83, $0.08 better than the analyst estimate of $0.75. Revenue for the quarter came in at $1.67B versus the consensus estimate of $1.66B.
Guidance
Crown Castle sees FY 2024 revenue of $6.37B versus the analyst consensus of $6.97B.
Crown Castle's stock price closed at $105.55. It is up 17.45% in the last 3 months and down -27.44% in the last 12 months.
Crown Castle saw 4 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Crown Castle's stock price’s past reactions to earnings here.
According to InvestingPro, Crown Castle's Financial Health score is "good performance".
Read Full Story »»»
DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Recent CCI News
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
